What have we learned from OxyContin?
J Pain Palliat Care Pharmacother
.
2003;17(1):1-4.
doi: 10.1080/j354v17n01_01.
Author
Arthur G Lipman
PMID:
14640335
DOI:
10.1080/j354v17n01_01
No abstract available
Publication types
Comment
Editorial
MeSH terms
Dose-Response Relationship, Drug
Humans
Narcotics / administration & dosage
Narcotics / adverse effects*
Oxycodone / administration & dosage
Oxycodone / adverse effects*
Substance-Related Disorders / diagnosis*
Substances
Narcotics
Oxycodone